Search research articles
Contact Us
Filters
Showing results (211-220 of 231) with videos related to
Page
of 24
Sort By:
Translational Psychiatry
|
January 25, 2017
Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume
M Berk, O Dandash, R Daglas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2020
Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
M Alyamani, J Li, M Patel, et al.
Journal of Internal Medicine
|
February 3, 2021
Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors
R Méndez, V Balanzá-Martínez, S C Luperdi, et al.
Acta Neuropsychiatrica
|
July 12, 2016
05-03 Disease burden of bipolar and schizoaffective disorder in an Australian cohort
A R de Castella, M Berk, P Fitzgerald, et al.
Acta Neuropsychiatrica
|
July 1, 2020
Interleukin-6 and total antioxidant capacity levels following <i>N</i>-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder
C C Bortolasci, C Voigt, A Turner, et al.
African Journal of Psychiatry
|
September 21, 2013
Deserves a hearing? A case report of remitting tinnitus with N-acetyl cysteine
O M Dean, S Jeavons, G S Malhi, et al.
Molecular Psychiatry
|
December 2, 2015
Citalopram and sertraline exposure compromises embryonic bone development
D Fraher, J M Hodge, F M Collier, et al.
Molecular Psychiatry
|
September 9, 2015
Citalopram and sertraline exposure compromises embryonic bone development
D Fraher, J M Hodge, F M Collier, et al.
Neuroscience and Biobehavioral Reviews
|
October 12, 2010
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
M Berk, F Kapczinski, A C Andreazza, et al.
Molecular Psychiatry
|
March 13, 2013
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
S Smesny, B Milleit, U-C Hipler, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 231) with videos related to
Sort By:
Page
of 24
Translational Psychiatry
|
January 25, 2017
Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume
M Berk, O Dandash, R Daglas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2020
Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
M Alyamani, J Li, M Patel, et al.
Journal of Internal Medicine
|
February 3, 2021
Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors
R Méndez, V Balanzá-Martínez, S C Luperdi, et al.
Acta Neuropsychiatrica
|
July 12, 2016
05-03 Disease burden of bipolar and schizoaffective disorder in an Australian cohort
A R de Castella, M Berk, P Fitzgerald, et al.
Acta Neuropsychiatrica
|
July 1, 2020
Interleukin-6 and total antioxidant capacity levels following <i>N</i>-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder
C C Bortolasci, C Voigt, A Turner, et al.
African Journal of Psychiatry
|
September 21, 2013
Deserves a hearing? A case report of remitting tinnitus with N-acetyl cysteine
O M Dean, S Jeavons, G S Malhi, et al.
Molecular Psychiatry
|
December 2, 2015
Citalopram and sertraline exposure compromises embryonic bone development
D Fraher, J M Hodge, F M Collier, et al.
Molecular Psychiatry
|
September 9, 2015
Citalopram and sertraline exposure compromises embryonic bone development
D Fraher, J M Hodge, F M Collier, et al.
Neuroscience and Biobehavioral Reviews
|
October 12, 2010
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
M Berk, F Kapczinski, A C Andreazza, et al.
Molecular Psychiatry
|
March 13, 2013
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
S Smesny, B Milleit, U-C Hipler, et al.
Page
of 24